Woman with cancer warns of rare breast implant risk

Woman with cancer warns of rare breast implant risk Susan Axelby has received £57,000 after developing a cancer linked to a type of breast implant. Breast cancer affects millions of women worldwide, and advancements in medical technology have provided various treatment options. One such option is breast reconstruction surgery, which often involves the use of breast implants. However, a recent case has brought attention to a rare risk associated with certain types of breast implants. Susan Axelby, a woman from the UK, has recently received £57,000 in compensation after developing a cancer linked to a specific type of breast implant. This case has raised concerns and highlights the need for greater awareness and understanding of potential risks associated with breast implants. Breast implants are medical devices that are used to enhance the size and shape of the breasts through surgery. They are often used for breast reconstruction after mastectomy or for cosmetic purposes. The two main types of breast implants are saline-filled and silicone gel-filled implants. In Susan Axelby's case, the cancer she developed is associated with a type of breast implant called textured implants. Textured implants have a rough outer surface, which is believed to help the implant remain in place and reduce the risk of capsular contracture, a condition where scar tissue forms around the implant and hardens. However, this rough surface texture may also increase the risk of a rare type of cancer called breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). BIA-ALCL is